American Equity Reports Solid Results in line with Expectations
American Equity Investment Life Holding Company (NYSE: AEL) reported Q1 2022 net income of $555.3 million, or $5.67 per diluted share, showing a year-over-year decline in earnings per share from $2.82 in Q1 2021. Non-GAAP operating income rose to $89.9 million, reflecting strong investment yields. The company repurchased $253 million in shares and sourced approximately $900 million in private assets. FIA sales hit $902 million, a 33% increase year-over-year, although down 10% sequentially. Expansion with Brookfield's North End Re increases product offerings and funding capacity.
- Q1 2022 net income of $555.3 million.
- Non-GAAP operating income of $89.9 million, up from $41.4 million in Q1 2021.
- FIA sales of $902 million, a 33% increase from Q1 2021.
- Successful share repurchase of $253 million.
- Expansion of reinsured products with Brookfield increasing capacity by $6 billion.
- Earnings per diluted share decreased from $2.82 in Q1 2021 to $5.67 in Q1 2022.
- FIA sales dropped 10% sequentially from the previous quarter.
Company Highlights
-
Q1 2022 net income available to common stockholders of
, or$555.3 million per diluted common share$5.67
-
Non-GAAP operating income1 available to common stockholders for the first quarter 2022 was
, or$89.9 million per diluted common share$0.92
-
Repurchased
or 6.3 million common shares year-to-date as of$253 million April 30
-
Private asset deployment momentum continues with approximately
sourced in the quarter$900 million
-
American Equity and Brookfield's North End Re (Cayman) SPC expand reinsured products, providing additional flow business and accelerating path to
of ceded liabilities$10 billion
Non-GAAP operating income1 available to common stockholders for the first quarter of 2022 was
The year-over-year increase in quarterly non-GAAP operating income1 available to common stockholders primarily reflected a substantial increase in average yield on invested assets due to strong returns on partnership and other market value investments and the significant reduction in cash balances over the last twelve months. The benefit of higher yield was partly offset by increases in the cost of money, other operating costs and expenses, and the increase in the liability for future policy benefits to be paid for lifetime income benefit riders (LIBR).
For the first quarter of 2022, net investment income increased
Compared to the first quarter of 2021, the change in the liability for future policy benefits to be paid for LIBR increased by
Compared to the first quarter of 2021, amortization of deferred policy acquisition and sales inducement costs decreased by
As of
DELIVERED ON INVESTMENT MANAGEMENT STRATEGIC GOALS
American Equity’s investment spread was
Average yield on invested assets was
Average cash and equivalents in the insurance companies' portfolios was
American Equity CEO & President
The aggregate cost of money for annuity liabilities of
First quarter sales were
On a sequential quarterly basis, FIA sales decreased
EXPANDED PRODUCT LINE TO BE REINSURED TO BROOKFIELD's NORTH END RE (CAYMAN) SPC
American Equity has executed an agreement with Brookfield's North End Re (Cayman) SPC to expand the company’s income products funding the additional
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
The forward-looking statements in this release or that American Equity uses on its conference call, such as anticipate, assuming, become, believe, calls for, can, continue, estimate, expect, forward, future, goal, going forward, grow, intend, likely, look to, may, need, next, on the way, on track, outlook, over time, plan, potential, predictable, project, ramp, should, signal, strategy, target, then, to be, toward, trends, will, would, and their derivative forms and similar words, as well as any projections of future results, are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" the company describes in its
CONFERENCE CALL
American Equity will hold a conference call to discuss first quarter 2022 earnings on
The call may also be accessed by telephone at 855-865-0606, passcode 1593835 (international callers, please dial 704-859-4382). An audio replay will be available shortly after the call on American Equity's website. An audio replay will also be available via telephone through
ABOUT AMERICAN EQUITY
At
1 Use of non-GAAP financial measures, including those that isolate notable items, is discussed in this release in the tables that follow the text of the release. |
2 Notional value represents the initial cash surrender value of business ceded subject to recurring fees under reinsurance agreements. |
3 Non-trendable items are the impact of investment yield – additional prepayment income and cost of money effect of over (under) hedging as shown in our |
4 For the purposes of this document, all references to sales are on a gross basis. Gross sales is defined as sales before the use of reinsurance. |
Unaudited (Dollars in thousands, except per share data)
Consolidated Statements of Operations
|
Three Months Ended
|
||||||
|
2022 |
|
2021 |
||||
Revenues: |
|
|
|
||||
Premiums and other considerations |
$ |
10,078 |
|
|
$ |
13,213 |
|
Annuity product charges |
|
52,355 |
|
|
|
60,082 |
|
Net investment income |
|
567,423 |
|
|
|
497,190 |
|
Change in fair value of derivatives |
|
(477,519 |
) |
|
|
396,305 |
|
Net realized losses on investments |
|
(13,127 |
) |
|
|
(4,583 |
) |
Other revenue |
|
8,589 |
|
|
|
— |
|
Total revenues |
|
147,799 |
|
|
|
962,207 |
|
|
|
|
|
||||
Benefits and expenses: |
|
|
|
||||
Insurance policy benefits and change in future policy benefits |
|
12,638 |
|
|
|
16,424 |
|
Interest sensitive and index product benefits |
|
372,662 |
|
|
|
476,595 |
|
Amortization of deferred sales inducements |
|
143,545 |
|
|
|
122,975 |
|
Change in fair value of embedded derivatives |
|
(1,393,649 |
) |
|
|
(282,413 |
) |
Interest expense on notes payable |
|
6,425 |
|
|
|
6,393 |
|
Interest expense on subordinated debentures |
|
1,317 |
|
|
|
1,326 |
|
Amortization of deferred policy acquisition costs |
|
225,426 |
|
|
|
203,823 |
|
Other operating costs and expenses |
|
58,120 |
|
|
|
55,865 |
|
Total benefits and expenses |
|
(573,516 |
) |
|
|
600,988 |
|
Income before income taxes |
|
721,315 |
|
|
|
361,219 |
|
Income tax expense |
|
155,092 |
|
|
|
78,535 |
|
Net income |
|
566,223 |
|
|
|
282,684 |
|
Less: Net income available to noncontrolling interests |
|
— |
|
|
|
— |
|
Net income available to |
|
566,223 |
|
|
|
282,684 |
|
Less: Preferred stock dividends |
|
10,919 |
|
|
|
10,919 |
|
Net income available to |
$ |
555,304 |
|
|
$ |
271,765 |
|
|
|
|
|
||||
Earnings per common share |
$ |
5.73 |
|
|
$ |
2.84 |
|
Earnings per common share - assuming dilution |
$ |
5.67 |
|
|
$ |
2.82 |
|
|
|
|
|
||||
Weighted average common shares outstanding (in thousands): |
|
|
|
||||
Earnings per common share |
|
96,866 |
|
|
|
95,735 |
|
Earnings per common share - assuming dilution |
|
97,953 |
|
|
|
96,216 |
|
Unaudited (Dollars in thousands, except per share data)
NON-GAAP FINANCIAL MEASURES
In addition to net income available to common stockholders, we have consistently utilized non-GAAP operating income available to common stockholders and non-GAAP operating income available to common stockholders per common share - assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Non-GAAP operating income available to common stockholders equals net income available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business. These adjustments are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income available to common stockholders together with net income available to common stockholders provides information that may enhance an investor’s understanding of our underlying results and profitability.
Reconciliation from Net Income Available to Common Stockholders to Non-GAAP Operating Income Available to Common Stockholders and Non-GAAP Operating Income Available to Common Stockholders, Excluding Notable Items
|
Three Months Ended
|
||||||
|
2022 |
|
2021 |
||||
Net income available to |
$ |
555,304 |
|
|
$ |
271,765 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
|
|
||||
Net realized losses on financial assets, including credit losses |
|
10,285 |
|
|
|
3,516 |
|
Change in fair value of derivatives and embedded derivatives |
|
(603,354 |
) |
|
|
(297,634 |
) |
Income taxes |
|
127,661 |
|
|
|
63,794 |
|
Non-GAAP operating income available to common stockholders |
|
89,896 |
|
|
|
41,441 |
|
Impact of notable items (b) |
|
— |
|
|
|
— |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
89,896 |
|
|
$ |
41,441 |
|
|
|
|
|
||||
Per common share - assuming dilution: |
|
|
|
||||
Net income available to |
$ |
5.67 |
|
|
$ |
2.82 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: |
|
|
|
||||
Net realized losses on financial assets, including credit losses |
|
0.11 |
|
|
|
0.04 |
|
Change in fair value of derivatives and embedded derivatives |
|
(6.16 |
) |
|
|
(3.09 |
) |
Income taxes |
|
1.30 |
|
|
|
0.66 |
|
Non-GAAP operating income available to common stockholders |
|
0.92 |
|
|
|
0.43 |
|
Impact of notable items |
|
— |
|
|
|
— |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
0.92 |
|
|
$ |
0.43 |
|
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Unaudited (Dollars in thousands, except share and per share data)
Book Value per Common Share
|
Q1 2022 |
||
Total stockholders’ equity attributable to |
$ |
5,171,086 |
|
Equity available to preferred stockholders (a) |
|
(700,000 |
) |
Total common stockholders' equity (b) |
|
4,471,086 |
|
Accumulated other comprehensive income |
|
(63,706 |
) |
Total common stockholders’ equity excluding AOCI (b) |
|
4,407,380 |
|
Net impact of fair value accounting for derivatives and embedded derivatives |
|
(750,229 |
) |
Total common stockholders’ equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
3,657,151 |
|
|
|
||
Common shares outstanding |
|
95,019,904 |
|
|
|
||
Book Value per Common Share: (c) |
|
||
Book value per common share |
$ |
47.05 |
|
Book value per common share excluding AOCI (b) |
$ |
46.38 |
|
Book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
38.49 |
(a) |
Equity available to preferred stockholders is equal to the redemption value of outstanding preferred stock plus share dividends declared but not yet issued. |
(b) |
Total common stockholders' equity, total common stockholders' equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, exclude equity available to preferred stockholders. Total common stockholders’ equity and book value per common share excluding AOCI, non-GAAP financial measures, are based on common stockholders’ equity excluding the effect of AOCI. Since AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale securities, we believe these non-GAAP financial measures provide useful supplemental information. Total common stockholders' equity and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, are based on common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives. Since the net impact of fair value accounting for our derivatives and embedded derivatives fluctuates from quarter to quarter and the most significant impacts relate to fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results, we believe these non-GAAP financial measures provide useful supplemental information. |
(c) |
Book value per common share including and excluding AOCI and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives are calculated as total common stockholders’ equity, total common stockholders’ equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives divided by the total number of shares of common stock outstanding. |
Unaudited (Dollars in thousands)
NON-GAAP FINANCIAL MEASURES
Average Common Stockholders' Equity and Return on Average Common Stockholders' Equity
Return on average common stockholders' equity measures how efficiently we generate profits from the resources provided by our net assets. Return on average common stockholders' equity is calculated by dividing net income available to common stockholders, for the trailing twelve months, by average equity available to common stockholders. Non-GAAP operating return on average common stockholders' equity excluding average accumulated other comprehensive income (AOCI) and average net impact of fair value accounting for derivatives and embedded derivatives is calculated by dividing non-GAAP operating income available to common stockholders, for the trailing twelve months, by average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives. We exclude AOCI because AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale investments. We exclude the net impact of fair value accounting for derivatives and embedded derivatives as the amounts are not economic in nature but rather impact the timing of reported results.
|
Twelve Months Ended |
||
|
|
||
Average Common Stockholders' Equity Attributable to |
|
||
Average total stockholders’ equity |
$ |
5,549,923 |
|
Average equity available to preferred stockholders |
|
(700,000 |
) |
Average equity available to common stockholders |
|
4,849,923 |
|
Average AOCI |
|
(784,483 |
) |
Average common stockholders' equity excluding average AOCI |
|
4,065,440 |
|
Average net impact of fair value accounting for derivatives and embedded derivatives |
|
(574,884 |
) |
Average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
3,490,556 |
|
Impact of notable items on average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
39,018 |
|
Average common stockholders' equity excluding average AOCI, average net impact of fair value accounting for derivatives and embedded derivatives and notables |
$ |
3,529,574 |
|
|
|
||
Net income available to |
$ |
713,856 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
||
Net realized losses on financial assets, including credit losses |
|
17,068 |
|
Change in fair value of derivatives and embedded derivatives |
|
(493,010 |
) |
Income taxes |
|
101,051 |
|
Non-GAAP operating income available to common stockholders |
|
338,965 |
|
Impact of notable items (b) |
|
78,036 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
417,001 |
|
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Net income available to common stockholders |
|
14.7 |
% |
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Non-GAAP operating income available to common stockholders |
|
9.7 |
% |
Non-GAAP operating income available to common stockholders, excluding notable items |
|
11.8 |
% |
Notable Items |
Twelve Months Ended |
||
|
|
||
Notable items impacting Non-GAAP operating income available to common stockholders: |
|
||
Impact of actuarial assumption updates |
$ |
78,036 |
|
Total notable items (b) |
$ |
78,036 |
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504006079/en/
(515) 273-3763, sschwartz@american-equity.com
Source:
FAQ
What were American Equity's Q1 2022 net income results?
How did American Equity's non-GAAP operating income perform in Q1 2022?
What was the impact of FIA sales for American Equity in Q1 2022?
Did American Equity engage in share repurchase during Q1 2022?